V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 320005885 | 320004224 | 1.9 | 76.3 | Palliative (P) | 2017-05-09 | 2017-05-10 | BCG Intravesical | 2 | N | 320018848 | IVA |
| 320005886 | 320004225 | 1.78 | 57.6 | Curative (C) | 2015-04-15 | 2015-04-15 | CARBOPLATIN + RT | 02 | Y | 320018852 | TEMOZOLOMIDE |
| 320005887 | 320004226 | 1.72 | 95.5 | Palliative (P) | 2015-01-24 | 2015-02-21 | CARBOPLATIN + RT | null | N | 320018907 | CARBOPLATIN + RT |
| 320005888 | 320005938 | 1.8 | 65.9 | Not known (9) | 2017-02-12 | 2017-02-12 | TCF | 02 | N | 320018927 | ENZALUTAMIDE |
| 320005889 | 320004227 | 1.63 | 63.65 | Palliative (P) | null | 2016-04-16 | Carbo F | 02 | null | 320019034 | CARBOPLATIN + DOCETAXEL |
| 320005890 | 320004230 | 1.68 | 84 | Palliative (P) | 2013-11-22 | 2014-09-20 | CARBOPLATIN + RT | 2 | N | 320019154 | Y-90 |
| 320005891 | 320004233 | 1.55 | 61 | Palliative (P) | 2016-04-06 | 2016-04-19 | Atezolizumab | 2 | N | 320019187 | CISPLATIN + VINORELBINE |
| 320005892 | 320004234 | 1.67 | 61.1 | Palliative (P) | 2015-12-25 | 2015-12-27 | DOXORUBICIN | N | N | 320019368 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 320005894 | 320004237 | null | null | Palliative (P) | 2018-04-22 | 2018-05-24 | Capecitabine + Cisplatin + RT | 02 | null | 320019483 | CAPE + CARBOPLATIN + CETUXIMAB |
| 320005895 | 320004238 | null | 70.3 | Palliative (P) | 2017-07-10 | 2017-07-14 | Docetaxel 75mg/m2 (21 day) | 02 | N | 320019595 | CARBOPLATIN + ETOPOSIDE |
| 320005896 | 320004238 | 1.77 | 74.4 | Palliative (P) | 2016-04-08 | 2016-04-08 | CARBOPLATIN + RT | Y | N | 320019595 | CARBOPLATIN + RT |
| 320005897 | 320004241 | 1.71 | 66 | Palliative (P) | 2015-01-17 | 2015-02-21 | PEMBROLIZUMAB | N | N | 320021184 | ETOPOSIDE + IFOSFAMIDE |
| 320005898 | 320004241 | 1.72 | 73.3 | Palliative (P) | 2017-05-03 | 2017-06-17 | VINCRISTINE | N | N | 320021184 | DACTINOMYCIN + CYCLO + VINCRISTINE |
| 320005899 | 320004243 | null | 89.4 | Palliative (P) | null | 2014-11-01 | CARBOPLATIN + VINORELBINE | N | N | 320021251 | BEVACIZUMAB + CAPE + OXALIPLATIN |
| 320005900 | 320004244 | 1.59 | 67 | Disease modification (D) | 2015-11-19 | 2015-12-04 | PEMBROLIZUMAB | N | N | 320021260 | BEVACIZUMAB + CARBO + GEMCITABINE |
| 320005901 | 320004245 | 1.67 | 65.7 | Curative (C) | null | 2018-04-22 | POUT TRIAL | N | N | 320021311 | CARBOPLATIN + RT |
| 320005902 | 320004245 | 0 | 78 | null | 2017-07-27 | 2017-08-18 | Cetuximab + Radiotherapy Maint | N | N | 320021311 | MVAC |
| 320005903 | 320004245 | 1.6 | 42.4 | Palliative (P) | 2018-01-09 | 2018-01-10 | BLEOMYCIN | 02 | N | 320021311 | NIVOLUMAB |
| 320005904 | 320004247 | 1.59 | null | Palliative (P) | 2017-01-06 | 2017-01-06 | Cetuximab+Cisplatin+FU (> Cycle 2) | 2 | N | 320021327 | DOCETAXEL |
| 320005905 | 320004248 | 1.87 | 80 | Palliative (P) | 2016-01-27 | 2016-02-24 | FLUOROURACIL + MITOMYCIN | N | N | 320021327 | CARBOPLATIN + RT |
| 320005906 | 320004251 | 1.57 | 54.6 | Palliative (P) | 2016-01-22 | 2016-01-22 | Irinotecan + Modified De Gramont | N | N | 320021389 | CAP |
| 320005907 | 320004253 | 1.6 | null | Adjuvant (A) | 2016-01-22 | 2016-01-29 | Cetuximab +Cisplatin + FU (Cycle 1) | N | N | 320021396 | CISPLATIN + GEMCITABINE |
| 320005908 | 320004255 | 1.7 | null | Palliative (P) | 2014-02-12 | 2014-02-26 | Doxorubicin + Ifosfamide | null | null | 320021407 | BEVACIZUMAB + CARBO + GEMCITABINE |
| 320005909 | 320004257 | 1.79 | null | null | 2015-12-17 | 2016-01-06 | CARBOPLATIN + RT | N | null | 320021412 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 320005910 | 320004258 | 1.55 | 57.9 | Curative (C) | 2018-03-05 | 2018-03-08 | PCV | N | N | 320021413 | BORTEZOMIB |
| 320005911 | 320004259 | 1.09 | 74.1 | Palliative (P) | 2018-05-09 | 2018-05-11 | Olaparib | N | N | 320021426 | CISPLATIN + GEMCITABINE |
| 320005912 | 320004261 | 1.56 | 60 | Palliative (P) | 2018-01-06 | 2018-02-08 | BEVACIZUMAB + CARBO + PACLITAXEL | 02 | N | 320021429 | OLAPARIB |
| 320005913 | 320004262 | 1.67 | 81.6 | Palliative (P) | 2016-03-06 | 2016-03-24 | Bevacizumab + CARBOPLATIN + PACLITAXEL | N | N | 320021512 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 320005914 | 320004263 | 1.67 | 58 | Curative (C) | 2015-11-02 | 2015-11-02 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 2 | N | 320021540 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 320005915 | 320004264 | null | 139 | Disease modification (D) | 2018-10-01 | 2018-11-12 | BEVACIZUMAB + CARBO + PACLITAXEL | 02 | null | 320021548 | NIRAPARIB |
| 320005916 | 320005955 | 1.53 | 81.2 | Palliative (P) | 2017-05-27 | 2017-05-28 | ICON8 TRIAL | N | N | 320021556 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 320005917 | 320005955 | 1.64 | 70.3 | Neo-adjuvant (N) | 2015-04-26 | 2015-05-12 | Cisplatin + Vinorelbine (IV) | N | N | 320021556 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 320005918 | 320004266 | 1.84 | 70 | Curative (C) | 2018-12-19 | 2019-01-20 | IMATINIB | N | Y | 320021588 | VIDE |
| 320005919 | 320004268 | 1.91 | 136.2 | Palliative (P) | 2017-05-16 | 2017-05-20 | PEMBROLIZUMAB | Y | N | 320021720 | AFLIBERCEPT + FU + IRINOTECAN |
| 320005920 | 320005956 | 1.7 | 56.7 | Palliative (P) | 2016-12-26 | 2016-12-26 | ICON8 TRIAL | 02 | N | 320021737 | CISPLATIN + GEMCITABINE |
| 320005921 | 320004269 | null | null | Adjuvant (A) | 2019-10-24 | 2019-10-25 | Carboplatin + Vinorelbine IV | 2 | N | 320021762 | CARBOPLATIN + CETUXIMAB + FU |
| 320005922 | 320004270 | 1.66 | null | Palliative (P) | null | 2016-03-15 | Docetaxel 75mg/m2 (21 day) | null | null | 320021766 | TRASTUZUMAB |
| 320005923 | 320005958 | null | 57.1 | null | null | 2014-04-21 | Bevacizumab+Carbo+Gemcitabine | N | N | 320021777 | NIVOLUMAB |
| 320005924 | 320004271 | 1.7 | 80.5 | Adjuvant (A) | 2016-03-08 | 2016-03-09 | IVA | 2 | N | 320021777 | CARBOPLATIN + RT |
| 320005925 | 320004272 | 1.43 | 76 | Palliative (P) | 2016-07-24 | 2016-07-24 | Sunitinib | 02 | N | 320021893 | VINBLASTINE |
| 320005926 | 320004275 | 0 | null | Neo-adjuvant (N) | 2014-03-28 | 2014-04-06 | Capecitabine (14 day) + Irinotecan | Y | N | 320021893 | GEMCITABINE |
| 320005927 | 320005961 | 1.7 | 105.8 | Palliative (P) | 2017-11-29 | 2017-12-20 | IVA | Y | null | 320022034 | TEMOZOLOMIDE |
| 320005928 | 320004277 | 1.68 | 64 | Palliative (P) | 2017-08-14 | 2017-08-15 | Capecitabine (21days) + Carboplatin | 02 | N | 320022034 | DOXORUBICIN + OLARATUMAB |
| 320005929 | 320006765 | 1.64 | 64.8 | Palliative (P) | 2015-04-02 | 2015-04-12 | Capecitabine + Cisplatin | 2 | N | 320022127 | ETOPOSIDE |
| 320005930 | 320004278 | 1.77 | 81.2 | Palliative (P) | 2016-05-04 | 2016-05-14 | IBRUTINIB | N | N | 320022208 | CARBOPLATIN + RT |
| 320005931 | 320004279 | 1.64 | null | Palliative (P) | 2016-08-13 | 2016-09-03 | LANREOTIDE | 02 | N | 320022266 | BCG |
| 320005932 | 320004279 | 1.67 | 54.1 | Palliative (P) | 2014-09-09 | 2014-10-20 | IMATINIB | N | N | 320022266 | POMALIDOMIDE |
| 320005933 | 320005963 | 1.46 | 85 | Not known (9) | 2017-12-15 | 2018-01-13 | BEVACIZUMAB + CARBO + PACLITAXEL | N | N | 320022339 | ICON TRIAL |
| 320005934 | 320005963 | 1.78 | null | Adjuvant (A) | 2017-09-07 | 2017-09-07 | FLUOROURACIL + MITOMYCIN + RT | N | N | 320022339 | ENZALUTAMIDE |
| 320005935 | 320004280 | 1.67 | 61.9 | Curative (C) | 2015-03-15 | 2015-03-18 | Docetaxel 75mg/m2 (21 day) | N | N | 320022352 | ECX |